The US FDA approves Phase 2 clinical trials of two innovative new drugs for rare disease treatment by Hanmi Pharmaceutical
Kyobo Life Insurance’s put option dispute prosecuted… Chairman Shin Chang-jae counterattacks’a new phase’
The Ministry of Food and Drug Safety recommends conditional permission to conduct Phase 3 of Celltrion
Ministry of Food and Drug Safety Advisory Group recommends conditional permission to conduct Phase 3 of Celltrion
[종합] Celltrion reduces the incidence of critically ill patients by 54% in phase 2 clinical trials of corona antibody treatment… Recovery period ↓